Teratocarcinomas are malignant gonadal tumors that contain an undifferentiated stem-cell population of embryonal carcinoma cells (EC cells), which are thought to be a good model system for investigating an early mammalian embryogenesis because they have many properties in common with the early normal embryonal cells (1) (2) (3) . The PA-1 cell is a human ovarian teratocarcinoma cell line obtained from ascitic fluid cells of recurrent malignant ovarian teratoma (4) and is known to express some embryonic character¬ istics. In particular, late-passage PA-1 cells are known to resemble EC cells because they form embryoid bodies and express the PCC4 antigen characteristic of embryonic blastocysts (4), but they lack the F9 antigen characteristic of two-cell and more developed preimplantation embryos. They are known also to be tumorigenic in nude mice and have activated ras oncogene (5) .
Epidermal growth factor (EGF) is a polypeptide of approximately 6000 D and is known as a potent mitogen. The biological effect of EGF is exerted through binding to a specific 170 000-D glycoprotein receptor. In mouse EC cells, EGF receptor is reported to exist in cryptic, intracellular latent forms (6) and increases in number by differentiation of EC cells (7) . Furthermore, low numbers of EGF receptors are expressed in human EC cells (8) . Undifferentiated 
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